Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 13, 2023

SELL
$0.96 - $2.92 $8,024 - $24,408
-8,359 Reduced 80.41%
2,037 $2,000
Q4 2022

Jan 23, 2023

SELL
$1.74 - $12.87 $46,706 - $345,469
-26,843 Reduced 72.08%
10,396 $0
Q3 2022

Oct 26, 2022

BUY
$7.21 - $14.88 $73,030 - $150,719
10,129 Added 37.36%
37,239 $446,000
Q2 2022

Jul 25, 2022

BUY
$5.97 - $9.97 $65,120 - $108,752
10,908 Added 67.33%
27,110 $226,000
Q1 2022

May 02, 2022

BUY
$8.44 - $12.49 $13,368 - $19,784
1,584 Added 10.84%
16,202 $140,000
Q4 2021

Jan 28, 2022

BUY
$10.12 - $14.07 $147,934 - $205,675
14,618 New
14,618 $165,000

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $93M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.